Wed, September 30, 2009
Tue, September 29, 2009
Mon, September 28, 2009
Fri, September 25, 2009
Thu, September 24, 2009
Wed, September 23, 2009
Tue, September 22, 2009
Mon, September 21, 2009
Fri, September 18, 2009
Thu, September 17, 2009
Wed, September 16, 2009
Tue, September 15, 2009
Mon, September 14, 2009
Fri, September 11, 2009
Thu, September 10, 2009
Wed, September 9, 2009
Tue, September 8, 2009
Sun, September 6, 2009
Fri, September 4, 2009
Thu, September 3, 2009
Wed, September 2, 2009
Tue, September 1, 2009
Mon, August 31, 2009
Fri, August 28, 2009
Thu, August 27, 2009
Wed, August 26, 2009
Tue, August 25, 2009
Mon, August 24, 2009
Sun, August 23, 2009
Fri, August 21, 2009
Thu, August 20, 2009
Wed, August 19, 2009
Tue, August 18, 2009
Mon, August 17, 2009
Sun, August 16, 2009
Fri, August 14, 2009
Thu, August 13, 2009
Wed, August 12, 2009
Tue, August 11, 2009
Mon, August 10, 2009
Fri, August 7, 2009
Thu, August 6, 2009
Wed, August 5, 2009

Oncothyreon to present at Rodman &; Renshaw Global Healthcare Conference


//health-fitness.news-articles.net/content/2009/ .. an-amp-renshaw-global-healthcare-conference.html
Published in Health and Fitness on Thursday, September 3rd 2009 at 5:14 GMT, Last Modified on 2009-11-02 11:47:26 by Market Wire   Print publication without navigation


 SEATTLE, WA, Sept. 3 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Rodman & Renshaw 11th Annual Healthcare Conference taking place Sept. 9-11, 2009 in New York. Dr. Kirkman will present at 2 p.m. Eastern Time on Thursday, Sept. 10. A live and archived webcast of the presentation will be accessible at[ http://www.wsw.com/webcast/rrshq15/onty ] or by visiting the Oncothyreon website[ www.oncothyreon.com ] under the "News & Events" section. About Oncothyreon Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit [ www.oncothyreon.com ].
For further information: Investor and Media Relations Contact: Julie Rathbun, Rathbun Communications, (206) 769-9219, [ ir@oncothyreon.com ]

Publication Contributing Sources

Similar Health and Fitness Publications